Anti-galectin-9 therapy synergizes with EGFR inhibition to reprogram the tumor microenvironment and overcome immune evasion

逃避(道德) 癌症研究 肿瘤微环境 医学 免疫系统 免疫疗法 半乳糖凝集素 半乳糖凝集素-3 免疫学
作者
Dongli Linghu,Jiaming Song,Liyan Gu,Chengjie Liu,Boning Liu,Ri‐Yao Yang,Qihui Chen,Jun Yao,Swathi Priya Manickam,Navaneethan Sundhar,Chih‐Yen Tu,Chia‐Hung Chen,Zhiguo Liu,Delong Liu,Hsiao‐Fan Chen,Shasha Shi,Siqi Xiong,Mien‐Chie Hung,Linlin Sun
出处
期刊:Journal for ImmunoTherapy of Cancer [BMJ]
卷期号:13 (7): e010926-e010926 被引量:3
标识
DOI:10.1136/jitc-2024-010926
摘要

Background Despite the remarkable clinical outcomes of epidermal growth factor receptor (EGFR)-targeted therapies in patients with lung cancer, therapeutic resistance eventually develops. This study elucidates the role of galectin-9 (Gal-9), a TIM-3 immune checkpoint ligand, in facilitating tumor immune escape during EGFR tyrosine kinase inhibitor (TKI) therapy, and evaluates the therapeutic potential of combined EGFR-TKI and Gal-9 blockade in preclinical models. Methods EGFR-TKI-mediated Gal-9 regulation was systematically investigated through multianalysis including RNA-seq transcriptomics, quantitative reverse transcription-PCR, immunoblotting, ELISA, flow cytometry, and immunohistochemical validation across human and murine lung/colorectal cancer cell lines, murine tumor tissues, and paired patient tumor tissues/serum samples. Therapeutic efficacy was evaluated in two syngeneic murine models, with comprehensive immune monitoring of tumor microenvironment (TME), tumor-draining lymph nodes (tdLNs), and splenic compartments. Mechanistic investigations employed CD8 + T-cell/macrophage depletion strategies (anti-CD8α monoclonal antibodies (mAbs)/PLX-3397), type I interferon (IFN-I) pathway inhibition (anti-IFNAR1 mAbs), and lymph node retention approaches (FTY720 administration). Results EGFR-TKI treatment significantly induced Gal-9 expression in both tumor cells and host immune cells, particularly myeloid cells. Clinical validation revealed elevated Gal-9 levels in EGFR-TKI-treated patient with lung cancer tumor tissues and serums, correlating with reduced progression-free survival. Mechanistically, EGFR-TKIs triggered DNA damage-potentiated cytosolic double-stranded DNA accumulation and activated tumor-intrinsic STING-IFN-I innate immune pathway that transcriptionally regulated Gal-9 expression. Notably, Gal-9-neutralizing antibodies synergized with EGFR-TKI to markedly inhibit tumor growth in two syngeneic mouse models, including the poorly immunogenic LLC lung tumor model unresponsive to programmed cell death protein-1/programmed death-ligand 1 blockade. The combination therapy remodeled myeloid landscapes toward antigen-presenting phenotypes, promoted dendritic cell accumulation in the tdLN and enhanced CD8 + T response in the TME. Depleting CD8 + T cells or macrophages/monocytes abrogated the therapeutic benefits. Blocking the IFN-I pathway attenuated Gal-9 expression and enhanced the antitumor immunity of afatinib in the LLC tumor model. Conclusions These findings identify Gal-9 upregulation as a key mechanism mediating immune evasion and limiting EGFR-TKI efficacy, providing a promising combinational therapeutic strategy of EGFR-TKI and Gal-9 blockade for the treatment of EGFR-driven cancers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
能干的钻石完成签到,获得积分10
刚刚
松松完成签到,获得积分20
刚刚
1秒前
如意元霜完成签到,获得积分10
1秒前
LSQ完成签到,获得积分10
1秒前
哈哈完成签到,获得积分10
1秒前
明月完成签到,获得积分10
2秒前
西瓜完成签到 ,获得积分10
2秒前
学术搭子完成签到,获得积分10
2秒前
2秒前
2秒前
ZZ完成签到 ,获得积分10
2秒前
阿龙完成签到,获得积分10
3秒前
3秒前
大月儿完成签到 ,获得积分10
3秒前
所所的应助被快乐友儿采纳,获得10
4秒前
LiKe完成签到 ,获得积分10
4秒前
赘婿的应助被daigang采纳,获得30
4秒前
汉堡包的应助被HU采纳,获得10
5秒前
姜汁完成签到 ,获得积分10
5秒前
二条完成签到,获得积分10
5秒前
5秒前
echo发布了新的文献求助10
5秒前
咿呀咿呀哟的应助被ypz采纳,获得10
6秒前
急聘行完成签到 ,获得积分10
6秒前
leotao发布了新的文献求助10
6秒前
脑洞疼的应助被安年采纳,获得10
6秒前
云宇完成签到 ,获得积分10
6秒前
小贾完成签到 ,获得积分10
7秒前
Yurith完成签到,获得积分10
7秒前
搜集达人的应助被顶刊相见采纳,获得10
7秒前
7秒前
星空发布了新的文献求助10
7秒前
一一完成签到,获得积分10
7秒前
初景发布了新的文献求助10
8秒前
一只盒子完成签到,获得积分10
8秒前
Akim的应助被风趣的水绿采纳,获得10
8秒前
自然菠萝完成签到,获得积分10
8秒前
乐乐完成签到,获得积分10
8秒前
hebnkygzs完成签到 ,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180488
求助须知:如何正确求助?哪些是违规求助? 9570437
关于积分的说明 21812406
捐赠科研通 7776516
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557516
邀请新用户注册赠送积分活动 2479162